MORGAN STANLEY - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$9,477
+31.5%
45,025
-0.0%
0.00%
Q1 2023$7,206
-73.0%
45,040
-6.5%
0.00%
Q4 2022$26,733
-54.7%
48,166
-2.3%
0.00%
Q3 2022$59,000
-59.0%
49,312
-78.5%
0.00%
Q2 2022$144,000
-48.9%
229,213
-7.6%
0.00%
Q1 2022$282,000
+24.2%
248,177
+146.6%
0.00%
Q4 2021$227,000
-82.0%
100,649
-72.7%
0.00%
Q3 2021$1,259,000
+43.7%
368,291
+25.7%
0.00%
Q2 2021$876,000
+14.8%
293,026
+24.1%
0.00%
Q1 2021$763,000
+1907.9%
236,031
+1222.6%
0.00%
Q4 2020$38,000
-7.3%
17,846
-49.4%
0.00%
Q3 2020$41,000
+355.6%
35,251
+268.9%
0.00%
Q2 2020$9,000
+50.0%
9,556
+20.7%
0.00%
Q1 2020$6,000
-25.0%
7,916
+3.1%
0.00%
Q4 2019$8,0000.0%7,680
-2.9%
0.00%
Q3 2019$8,000
-57.9%
7,909
-24.0%
0.00%
Q2 2019$19,000
-17.4%
10,401
-12.5%
0.00%
Q1 2019$23,000
+475.0%
11,885
+318.3%
0.00%
Q4 2018$4,000
-93.5%
2,841
-87.5%
0.00%
Q3 2018$62,000
+93.8%
22,745
+36.1%
0.00%
Q2 2018$32,000
-15.8%
16,718
-7.9%
0.00%
Q1 2018$38,000
+46.2%
18,149
+43.1%
0.00%
Q4 2017$26,000
-76.8%
12,684
-85.0%
0.00%
Q3 2017$112,000
-32.9%
84,370
-20.8%
0.00%
Q2 2017$167,000
-62.2%
106,512
-22.3%
0.00%
Q1 2017$442,000
-9.8%
137,010
-62.4%
0.00%
Q4 2016$490,000
+716.7%
364,310
+858.2%
0.00%
Q3 2016$60,000
+1.7%
38,020
-13.9%
0.00%
Q2 2016$59,000
-76.3%
44,173
-6.4%
0.00%
Q1 2016$249,000
+11.2%
47,211
+65.7%
0.00%
Q4 2015$224,000
-34.3%
28,492
-29.6%
0.00%
Q3 2015$341,000
-82.2%
40,468
-76.9%
0.00%
-100.0%
Q2 2015$1,919,000
-14.9%
175,199
+8.7%
0.00%0.0%
Q1 2015$2,254,000
-39.4%
161,207
-26.8%
0.00%0.0%
Q4 2014$3,719,000
+30.8%
220,112
+3.9%
0.00%0.0%
Q3 2014$2,843,000
+116.5%
211,868
+105.4%
0.00%0.0%
Q2 2014$1,313,000
+286.2%
103,137
+260.4%
0.00%
Q1 2014$340,000
-75.2%
28,614
-71.2%
0.00%
-100.0%
Q4 2013$1,371,000
+11.5%
99,212
+40.6%
0.00%0.0%
Q3 2013$1,230,000
-49.2%
70,569
-52.8%
0.00%0.0%
Q2 2013$2,419,000149,4160.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 9,766,508$19,826,0002.39%
PLATINUM INVESTMENT MANAGEMENT LTD 1,286,032$2,610,0000.07%
Clear Harbor Asset Management, LLC 153,800$312,0000.06%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 219,652$445,0000.03%
Rock Springs Capital Management LP 270,000$548,0000.02%
Alambic Investment Management, L.P. 77,665$158,0000.02%
Marshall Wace North America L.P. 1,173,515$2,382,0000.01%
Baker Brothers Advisors 580,400$1,178,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$932,0000.01%
Intellectus Partners, LLC 13,000$26,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders